Siga Technologies (SIGA) Other Non-Current Liabilities (2011 - 2025)
Siga Technologies (SIGA) reported Other Non-Current Liabilities of $2.7 million for Q4 2025, down 17.1% on a YoY basis from $3.2 million in Q4 2024, and down 19.15% quarter-over-quarter from $3.3 million in Q3 2025.
Siga Technologies (SIGA) Other Non-Current Liabilities (2011 - 2025) Analysis & Trends
Siga Technologies has reported Other Non-Current Liabilities for 15 years, with the latest figure at $2.7 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Liabilities fell 17.1% year-over-year to $2.7 million; the trailing twelve-month figure through Dec 2025 stood at $2.7 million (down 17.1% YoY), and the FY2025 full-year result was $2.7 million, down 17.1% from the prior year.
- Other Non-Current Liabilities for Q4 2025 stood at $2.7 million, down from $3.3 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $6.5 million in Q4 2021, with the low at $2.7 million in Q4 2025.
- Historically, Other Non-Current Liabilities has averaged $4.0 million across 5 years, with a median of $3.4 million in 2023.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities plunged 52.06% — and 2024, when it advanced 7.93%.
- Siga Technologies' Other Non-Current Liabilities stood at $6.5 million in 2021, then tumbled by 48.51% to $3.4 million in 2022, then grew by 0.54% to $3.4 million in 2023, then retreated by 5.2% to $3.2 million in 2024, then declined by 17.1% to $2.7 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $2.7 million (Q4 2025), $3.3 million (Q3 2025), and $3.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Siga Technologies | 314.73 Mn | 159.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.65 Mn |
| Sep 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 3.13 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 3.38 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 3.35 Mn |
| Dec 31, 2022 | 3.36 Mn |
| Sep 30, 2022 | 3.63 Mn |
| Mar 31, 2022 | 6.17 Mn |
| Dec 31, 2021 | 6.52 Mn |
| Sep 30, 2021 | 6.34 Mn |
| Jun 30, 2021 | 3.72 Mn |
| Mar 31, 2021 | 5.72 Mn |
| Dec 31, 2020 | 6.64 Mn |